ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

TOIIW Oncology Institute Inc

0.0996
0.00 (0.00%)
May 10 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 18
Bid Price 0.085
Ask Price 0.135
News -
Day High

Low
0.022

52 Week Range

High
0.3699

Day Low
Company Name Stock Ticker Symbol Market Type
Oncology Institute Inc TOIIW NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.0996 16:00:00
Open Price Low Price High Price Close Price Prev Close
0.0996 0.0996
Trades Volume Avg Volume 52 Week Range
1 18 - 0.022 - 0.3699
Last Trade Time Type Quantity Stock Price Currency
09:17:27 18 $ 0.085 USD

Oncology Institute Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
809.76M 73.75M - 324.24M -83.07M -1.13 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Oncology Institute News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No TOIIW Message Board. Create One! See More Posts on TOIIW Message Board See More Message Board Posts

Historical TOIIW Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.1670.1720.0750.116771940,924-0.0674-40.36%
1 Month0.21010.24750.0750.120587611,720-0.1105-52.59%
3 Months0.25010.29750.0750.181447512,945-0.1505-60.18%
6 Months0.230.36990.0750.19348997,696-0.1304-56.70%
1 Year0.07890.36990.0220.097435211,7090.020726.24%
3 Years1.7751.7750.0220.548049417,396-1.68-94.39%
5 Years1.7751.7750.0220.548049417,396-1.68-94.39%

Oncology Institute Description

The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financia, counseling, clinical trials, comprehensive lab testing, and end-of-life counseling.The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services.